UNSPSC 51101618: Taurolidine

This classification denotes an antibiotic with the molecular formula C7H16N4O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8OBZ1M4V3V, chemically known as 4,4-methylenebis(tetrahydro-1,2,4-thiadiazine 1,1-dioxide) but generally known as taurolidine, which bears US NIH Compound Identifier 29566. European Medicines Agency schedules Taurolidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10837MIG.

UNSPSC 51101618 Taurolidine is a Commodity code for a specific pharmaceutical active ingredient; however, recent state and local procurement activity shows little direct purchasing of taurolidine itself. The two most recent state and local opportunities tagged to this code involve different pharmaceutical products entirely—the Illinois Department of Public Health's award to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride through a MMCAP Infuse cooperative purchasing piggyback, and Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems. State and local health departments and county public health agencies are the primary issuing bodies under this code, purchasing pharmaceutical supplies through cooperative procurement vehicles and competitive bidding to support public health operations and emergency preparedness. The scope includes both established antibiotic medications and opioid-reversal agents, reflecting a mix of routine health inventory and harm-reduction initiatives.

The geographic spread includes Illinois and Florida in recent postings, with activity concentrated in state health department procurement and county-level public health agencies. The Illinois Department of Public Health awarded a $2,999,999.11 contract over three years to Chartwell Rx LLC for pharmaceutical warehouse supply via the MMCAP Infuse consortium on August 28, 2026 through an IFB process. Seminole County, Florida released an IFB on June 30, 2026 (response deadline July 26, 2023, noted as a past date in the source) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford. Neither opportunity directly solicited taurolidine; the code-opportunity mismatch suggests this Commodity code sees limited direct state and local purchasing activity or may be applied inconsistently in jurisdictional procurement systems.